# FDA Inspection 1287906 - Reese Pharmaceutical Company - September 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/7bb2fa6a-3bb3-4c25-8de4-03c2fa5679b0
Source feed: FDA_Inspections

> FDA Inspection 1287906 for Reese Pharmaceutical Company on September 25, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287906
- Company Name: Reese Pharmaceutical Company
- Inspection Date: 2025-09-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287906 - 2025-09-25](https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/f4610636-683b-4044-b73a-4eae3b23d584)
- [FDA Inspection 1160702 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/cdb0a460-fa7f-4a40-a225-f9d121134ac0)
- [FDA Inspection 1160702 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/10c4b7e6-409f-4380-9e5a-2d481f0e6765)
- [FDA Inspection 1160701 - 2021-12-08](https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/8c428209-ae01-49fe-8b32-b7b17562d858)
- [FDA Inspection 1160701 - 2021-12-08](https://www.keypedia.com/records/fda_inspections/reese-pharmaceutical-company/19c0b3ab-ac3e-4a0f-819c-68dd6f9586d8)

Company: https://www.keypedia.com/companies/reese-pharmaceutical-company/8eb10f05-b060-421f-a56f-22fbb96e4a97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c